全球胰島素筆市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032）

主要發現

• 胰島素筆市場規模：84.069億美元（2025年）
• 預計市場價值：145.958億美元（2032年）
• 全球市場成長率：8.2%（2025年至2032年的複合年成長率）

胰島素筆市場：報告範圍

胰島素筆是糖尿病患者用來注射胰島素的醫療設備，與傳統的管瓶和注射器注射方式相比，它更方便、更準確且易於使用。胰島素筆市場包括可重複使用和一次性胰島素筆，以及整合數位技術的智慧胰島素筆。這些設備主要用於1型和第2型糖尿病患者的居家照護和臨床治療。推動市場成長的因素包括全球糖尿病盛行率的上升、對自主給藥設備的需求不斷成長，以及胰島素筆設計和連接技術的進步。

市場成長動力

全球胰島素筆市場受多種因素驅動，包括全球糖尿病盛行率的不斷上升，以及對使用者友好且隱藏的胰島素注射解決方案日益成長的需求。提高患者依從性、減輕注射疼痛以及提高給藥準確性是推動其普及的關鍵優勢。具有劑量追蹤、藍牙連接以及與糖尿病管理應用程式整合功能的智慧胰島素筆的推出，將進一步推動市場成長。此外，新興經濟體政府為提高糖尿病認知度和擴大醫療保健覆蓋範圍而採取的舉措，也有助於提升市場滲透率。

市場限制

儘管成長前景光明，胰島素筆市場仍面臨成本、報銷政策和設備召回等挑戰。胰島素筆（尤其是智慧胰島素筆）價格高昂，限制了其在中低收入地區的普及。此外，各國報銷政策不一致以及對不同類型胰島素筆造成的浪費的擔憂也阻礙了市場的成長。由於機械故障和給藥失誤導致的設備故障和產品召回也會影響使用者信心，並為製造商帶來監管障礙。

市場機會

隨著數位醫療的日益融合以及尚未開發的市場的不斷擴張，胰島素筆市場蘊藏著巨大的機會。糖尿病患者人數不斷成長的新興經濟體擁有豐厚的成長潛力，尤其是在在地化生產和定價策略的推動下。醫療設備公司與數位健康平台合作開發具有即時血糖監測、劑量提醒和分析功能的智慧筆，將創造新的收益來源。此外，加大對微型化、環保和以患者為中心的設備研發投入，預計將推動技術創新和競爭優勢。

本報告研究了全球胰島素筆市場，評估了成長動力、趨勢、機會和挑戰等關鍵市場動態，並對市場結構提供了深入的見解。

目錄

第1章執行摘要

第2章 市場概述

• 市場範圍和定義
• 價值鏈分析
• 宏觀經濟因素
  • 全球GDP展望
  • 全球GDP展望
  • 全球經濟成長預測
  • 全球都市化進程
  • 其他宏觀經濟因素
• 預測因子－相關性和影響力
• 評估COVID-19的影響
• PESTLE分析
• 波特五力分析
• 地緣政治緊張局勢：其對市場的影響
• 監管和技術格局

第3章 市場動態

• 驅動程式
• 抑制因素
• 機會
• 趨勢

第4章 價格趨勢分析（2019-2032）

• 區域定價分析
• 價格：按細分市場
• 影響價格的因素

第5章 全球胰島素筆市場展望：實際結果（2019-2024 年）與預測（2025-2032 年）

• 主要亮點
• 全球胰島素筆市場展望：產品
  • 簡介/主要發現
  • 市場規模績效分析：依產品（2019-2024 年）
  • 按產品分類的當前市場規模預測（2025-2032）
    • 可重複使用的胰島素筆
    • 拋棄式胰島素筆
    • 智慧胰島素筆
  • 市場吸引力分析：產品
• 全球胰島素筆市場展望：適應症
  • 簡介/主要發現
  • 市場規模績效分析：按適應症（2019-2024）
  • 目前市場規模預測（依適應症分類）（2025-2032）
    • 1型糖尿病
    • 2型糖尿病
  • 市場吸引力分析：跡象
• 全球胰島素筆市場展望：通路
  • 簡介/主要發現
  • 市場規模績效分析：按分銷管道（2019-2024）
  • 按分銷管道分類的當前市場規模預測（2025-2032）
    • 醫院藥房
    • 藥局
    • 零售藥局
    • 網路藥局
  • 市場吸引力分析：分銷管道

第6章 全球胰島素筆市場（按地區）展望

• 主要亮點
• 市場規模績效分析：按地區（2019-2024）
• 目前市場規模預測：按地區（2025-2032）
  • 北美洲
  • 歐洲
  • 東亞
  • 南亞和大洋洲
  • 拉丁美洲
  • 中東和非洲
• 市場吸引力分析：地區

第7章。北美胰島素筆市場展望：實際（2019-2024 年）與預測（2025-2032 年）

第 8 章。歐洲胰島素筆市場展望：實際（2019-2024 年）與預測（2025-2032 年）

第9章東亞胰島素筆市場展望：實際結果（2019-2024 年）和預測（2025-2032 年）

第 10 章。南亞和大洋洲胰島素筆市場展望：實際（2019-2024 年）和預測（2025-2032 年）

第 11 章：拉丁美洲胰島素筆市場展望：實際結果（2019-2024 年）和預測（2025-2032 年）

第 12 章。中東和非洲胰島素筆市場展望：實際結果（2019-2024 年）和預測（2025-2032 年）

第13章競爭格局

• 市場佔有率分析（2025年）
• 市場結構
  • 競賽實力圖譜
  • 競爭對手儀表板
• 公司簡介
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi
  • Medtronic plc.
  • Ypsomed AG
  • Stevanato Group
  • Solteam Incorporation Co.

第14章 附錄

Persistence Market Research has recently released a comprehensive report on the worldwide market for insulin pens. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Insulin Pens Market Size (2025E): USD 8,406.90 Million
• Projected Market Value (2032F): USD 14,595.80 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 8.2%

Insulin Pens Market - Report Scope:

Insulin pens are medical devices used for the administration of insulin in diabetic patients, offering greater convenience, accuracy, and ease of use compared to traditional vial and syringe methods. The insulin pens market encompasses reusable and disposable pens, along with smart insulin pens integrated with digital technologies. These devices are primarily adopted by Type 1 and Type 2 diabetes patients for homecare and clinical use. Market growth is fueled by increasing global diabetes prevalence, rising demand for self-administration devices, and technological advancements in pen design and connectivity.

Market Growth Drivers:

The global insulin pens market is propelled by several key factors, including the growing incidence of diabetes worldwide and the increasing demand for user-friendly and discreet insulin delivery solutions. Enhanced patient adherence, reduced injection pain, and improved dosage accuracy are major benefits driving adoption. The introduction of smart insulin pens with dose tracking, Bluetooth connectivity, and integration with diabetes management apps further accelerates market growth. Additionally, government initiatives promoting diabetes awareness and the expansion of healthcare access in emerging economies contribute to increased market penetration.

Market Restraints:

Despite positive growth prospects, the insulin pens market faces challenges related to cost, reimbursement policies, and device recalls. High prices of insulin pens, especially smart variants, limit adoption in low- and middle-income regions. Furthermore, inconsistent reimbursement policies across different countries and concerns over insulin wastage with certain pen types hinder market growth. Device malfunctions and product recalls due to mechanical or dosage errors also impact user trust and present regulatory hurdles for manufacturers.

Market Opportunities:

The insulin pens market presents significant opportunities through advancements in digital health integration and expansion in untapped markets. Emerging economies with growing diabetic populations offer lucrative growth potential, especially with localized manufacturing and pricing strategies. Partnerships between medical device firms and digital health platforms to develop smart pens with real-time glucose monitoring, dose reminders, and analytics create new revenue streams. Moreover, increased investment in R\&D for miniaturized, eco-friendly, and patient-centric devices is expected to drive innovation and competitive advantage.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the insulin pens market globally?
• Which pen types and technologies are enhancing diabetes management in different healthcare settings?
• How are smart innovations and digital integration reshaping the insulin pens market landscape?
• Who are the major players in the insulin pens market and what strategies are being implemented for growth?
• What are the emerging trends and future outlook for the global insulin pens market?

Competitive Intelligence and Business Strategy:

Leading companies in the insulin pens market, including Novo Nordisk A/S, Sanofi S.A., Eli Lilly and Company, and BD (Becton, Dickinson and Company), focus on product innovation, strategic collaborations, and expanding geographic reach. These firms are investing in advanced smart insulin pens and user-centric design features to enhance therapy compliance. Strategic partnerships with digital health companies and expansion into Asia Pacific and Latin American markets enable sustained growth. Furthermore, ongoing clinical research, patient support programs, and value-based care initiatives play a key role in market expansion and improved patient outcomes.

Key Companies Profiled:

• Novo Nordisk A/S
• Eli Lilly and Company
• Sanofi
• Medtronic plc.
• Ypsomed AG
• Stevanato Group
• Solteam Incorporation Co.

Insulin Pens Market Research Segmentation:

Product:

• Reusable Insulin Pens
• Disposable Insulin Pens
• Smart Insulin Pens

Indication:

• Diabetes Type I
• Diabetes Type II

Distribution Channel:

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Insulin Pens Market Snapshot 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Industry Developments and Key Market Events
• 1.5. Demand Side and Supply Side Analysis
• 1.6. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definitions
• 2.2. Value Chain Analysis
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Outlook
  • 2.3.2. Global GDP Outlook
  • 2.3.3. Global economic Growth Forecast
  • 2.3.4. Global Urbanization Growth
  • 2.3.5. Other Macro-economic Factors
• 2.4. Forecast Factors - Relevance and Impact
• 2.5. COVID-19 Impact Assessment
• 2.6. PESTLE Analysis
• 2.7. Porter's Five Forces Analysis
• 2.8. Geopolitical Tensions: Market Impact
• 2.9. Regulatory and Technology Landscape

3. Market Dynamics

• 3.1. Drivers
• 3.2. Restraints
• 3.3. Opportunities
• 3.4. Trends

4. Price Trend Analysis, 2019-2032

• 4.1. Region-wise Price Analysis
• 4.2. Price by Segments
• 4.3. Price Impact Factors

5. Global Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 5.1. Key Highlights
• 5.2. Global Insulin Pens Market Outlook: Product
  • 5.2.1. Introduction/Key Findings
  • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
  • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 5.2.3.1. Reusable Insulin Pens
    • 5.2.3.2. Disposable Insulin Pens
    • 5.2.3.3. Smart Insulin Pens
  • 5.2.4. Market Attractiveness Analysis: Product
• 5.3. Global Insulin Pens Market Outlook: Indication
  • 5.3.1. Introduction/Key Findings
  • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
  • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 5.3.3.1. Diabetes Type I
    • 5.3.3.2. Diabetes Type II
  • 5.3.4. Market Attractiveness Analysis: Indication
• 5.4. Global Insulin Pens Market Outlook: Distribution Channel
  • 5.4.1. Introduction/Key Findings
  • 5.4.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
  • 5.4.3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
    • 5.4.3.1. Hospital Pharmacies
    • 5.4.3.2. Drug Stores
    • 5.4.3.3. Retail Pharmacies
    • 5.4.3.4. Online Pharmacies
  • 5.4.4. Market Attractiveness Analysis: Distribution Channel

6. Global Insulin Pens Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
• 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia & Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 7.4.1. Reusable Insulin Pens
  • 7.4.2. Disposable Insulin Pens
  • 7.4.3. Smart Insulin Pens
• 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 7.5.1. Diabetes Type I
  • 7.5.2. Diabetes Type II
• 7.6. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 7.6.1. Hospital Pharmacies
  • 7.6.2. Drug Stores
  • 7.6.3. Retail Pharmacies
  • 7.6.4. Online Pharmacies

8. Europe Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 8.3.1. Germany
  • 8.3.2. Italy
  • 8.3.3. France
  • 8.3.4. U.K.
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Rest of Europe
• 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 8.4.1. Reusable Insulin Pens
  • 8.4.2. Disposable Insulin Pens
  • 8.4.3. Smart Insulin Pens
• 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 8.5.1. Diabetes Type I
  • 8.5.2. Diabetes Type II
• 8.6. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 8.6.1. Hospital Pharmacies
  • 8.6.2. Drug Stores
  • 8.6.3. Retail Pharmacies
  • 8.6.4. Online Pharmacies

9. East Asia Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 9.4.1. Reusable Insulin Pens
  • 9.4.2. Disposable Insulin Pens
  • 9.4.3. Smart Insulin Pens
• 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 9.5.1. Diabetes Type I
  • 9.5.2. Diabetes Type II
• 9.6. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 9.6.1. Hospital Pharmacies
  • 9.6.2. Drug Stores
  • 9.6.3. Retail Pharmacies
  • 9.6.4. Online Pharmacies

10. South Asia & Oceania Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of SAO
• 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 10.4.1. Reusable Insulin Pens
  • 10.4.2. Disposable Insulin Pens
  • 10.4.3. Smart Insulin Pens
• 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 10.5.1. Diabetes Type I
  • 10.5.2. Diabetes Type II
• 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 10.6.1. Hospital Pharmacies
  • 10.6.2. Drug Stores
  • 10.6.3. Retail Pharmacies
  • 10.6.4. Online Pharmacies

11. Latin America Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of LATAM
• 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 11.4.1. Reusable Insulin Pens
  • 11.4.2. Disposable Insulin Pens
  • 11.4.3. Smart Insulin Pens
• 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 11.5.1. Diabetes Type I
  • 11.5.2. Diabetes Type II
• 11.6. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 11.6.1. Hospital Pharmacies
  • 11.6.2. Drug Stores
  • 11.6.3. Retail Pharmacies
  • 11.6.4. Online Pharmacies

12. Middle East & Africa Insulin Pens Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 12.1. Key Highlights
• 12.2. Pricing Analysis
• 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
  • 12.3.1. GCC Countries
  • 12.3.2. South Africa
  • 12.3.3. Northern Africa
  • 12.3.4. Rest of MEA
• 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
  • 12.4.1. Reusable Insulin Pens
  • 12.4.2. Disposable Insulin Pens
  • 12.4.3. Smart Insulin Pens
• 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  • 12.5.1. Diabetes Type I
  • 12.5.2. Diabetes Type II
• 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  • 12.6.1. Hospital Pharmacies
  • 12.6.2. Drug Stores
  • 12.6.3. Retail Pharmacies
  • 12.6.4. Online Pharmacies

13. Competition Landscape

• 13.1. Market Share Analysis, 2025
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles
  • 13.3.1. Novo Nordisk A/S
    • 13.3.1.1. Company Overview
    • 13.3.1.2. Product Portfolio/Offerings
    • 13.3.1.3. Key Financials
    • 13.3.1.4. SWOT Analysis
    • 13.3.1.5. Company Strategy and Key Developments
  • 13.3.2. Eli Lilly and Company
  • 13.3.3. Sanofi
  • 13.3.4. Medtronic plc.
  • 13.3.5. Ypsomed AG
  • 13.3.6. Stevanato Group
  • 13.3.7. Solteam Incorporation Co.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations